351 related articles for article (PubMed ID: 20862616)
21. Lentiviral strategies for RNAi knockdown of neuronal genes.
Crittenden JR; Heidersbach A; McManus MT
Curr Protoc Neurosci; 2007 Apr; Chapter 5():Unit 5.26. PubMed ID: 18428658
[TBL] [Abstract][Full Text] [Related]
22. Gene therapy for neurodegenerative and ocular diseases using lentiviral vectors.
Ralph GS; Binley K; Wong LF; Azzouz M; Mazarakis ND
Clin Sci (Lond); 2006 Jan; 110(1):37-46. PubMed ID: 16336203
[TBL] [Abstract][Full Text] [Related]
23. Lentiviral transgenesis.
Pfeifer A; Hofmann A
Methods Mol Biol; 2009; 530():391-405. PubMed ID: 19266335
[TBL] [Abstract][Full Text] [Related]
24. Virus-delivered RNA interference in mouse brain to study addiction-related behaviors.
Lasek AW; Azouaou N
Methods Mol Biol; 2010; 602():283-98. PubMed ID: 20012405
[TBL] [Abstract][Full Text] [Related]
25. Short-term cytotoxic effects and long-term instability of RNAi delivered using lentiviral vectors.
Fish RJ; Kruithof EK
BMC Mol Biol; 2004 Aug; 5():9. PubMed ID: 15291968
[TBL] [Abstract][Full Text] [Related]
26. Strategies for retargeted gene delivery using vectors derived from lentiviruses.
Bartosch B; Cosset FL
Curr Gene Ther; 2004 Dec; 4(4):427-43. PubMed ID: 15578992
[TBL] [Abstract][Full Text] [Related]
27. [Lentiviral vector-mediated Nanog short-hairpin RNA inhibits the growth of human gastric carcinoma xenograft in nude mice].
Li K; Jiang Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):18-22. PubMed ID: 25575052
[TBL] [Abstract][Full Text] [Related]
28. Efficient lentiviral vectors for short hairpin RNA delivery into human cells.
An DS; Xie Y; Mao SH; Morizono K; Kung SK; Chen IS
Hum Gene Ther; 2003 Aug; 14(12):1207-12. PubMed ID: 12908971
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral small hairpin RNA delivery reduces apical sodium channel activity in differentiated human airway epithelial cells.
Aarbiou J; Copreni E; Buijs-Offerman RM; van der Wegen P; Castellani S; Carbone A; Tilesi F; Fradiani P; Hiemstra PS; Yueksekdag G; Diana A; Rosenecker J; Ascenzioni F; Conese M; Scholte BJ
J Gene Med; 2012 Dec; 14(12):733-45. PubMed ID: 23074129
[TBL] [Abstract][Full Text] [Related]
30. Lentiviral vector-mediated doxycycline-inducible USP39 shRNA or cDNA expression in triple-negative breast cancer cells.
Liu S; Liu X; Wang H; Zhou Q; Liang Y; Sui A; Yao R; Zhao B; Sun M
Oncol Rep; 2015 May; 33(5):2477-83. PubMed ID: 25812575
[TBL] [Abstract][Full Text] [Related]
31. Lentiviral-mediated RNA interference.
Abbas-Terki T; Blanco-Bose W; Déglon N; Pralong W; Aebischer P
Hum Gene Ther; 2002 Dec; 13(18):2197-201. PubMed ID: 12542850
[TBL] [Abstract][Full Text] [Related]
32. Modulation of gene expression by lentiviral-mediated delivery of small interfering RNA.
Scherr M; Battmer K; Ganser A; Eder M
Cell Cycle; 2003; 2(3):251-7. PubMed ID: 12734435
[TBL] [Abstract][Full Text] [Related]
33. In vivo manipulation of gene expression in non-human primates using lentiviral vectors as delivery vehicles.
Dissen GA; Lomniczi A; Neff TL; Hobbs TR; Kohama SG; Kroenke CD; Galimi F; Ojeda SR
Methods; 2009 Sep; 49(1):70-7. PubMed ID: 19559089
[TBL] [Abstract][Full Text] [Related]
34. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
Li MJ; Rossi JJ
Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
[TBL] [Abstract][Full Text] [Related]
35. Enhancement of the transduction efficiency of a lentiviral vector for neuron-specific retrograde gene delivery through the point mutation of fusion glycoprotein type E.
Kato S; Sugawara M; Kobayashi K; Kimura K; Inoue KI; Takada M; Kobayashi K
J Neurosci Methods; 2019 Jan; 311():147-155. PubMed ID: 30347222
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy for neurodegenerative diseases based on lentiviral vectors.
Nanou A; Azzouz M
Prog Brain Res; 2009; 175():187-200. PubMed ID: 19660657
[TBL] [Abstract][Full Text] [Related]
37. Lentiviral-mediated RNA interference against TGF-beta receptor type II in renal epithelial and fibroblast cell populations in vitro demonstrates regulated renal fibrogenesis that is more efficient than a nonlentiviral vector.
Yang T; Zhang B; Pat BK; Wei MQ; Gobe GC
J Biomed Biotechnol; 2010; 2010():859240. PubMed ID: 21151672
[TBL] [Abstract][Full Text] [Related]
38. Intrathecal lentiviral-mediated RNA interference targeting PKCγ attenuates chronic constriction injury-induced neuropathic pain in rats.
Zou W; Song Z; Guo Q; Liu C; Zhang Z; Zhang Y
Hum Gene Ther; 2011 Apr; 22(4):465-75. PubMed ID: 21087146
[TBL] [Abstract][Full Text] [Related]
39. [Construction and identification of lentiviral vector mediated GATA-3 gene RNA interference in mouse].
Li YX; He XG; Yao YG; Wang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Apr; 31(8):627-632. PubMed ID: 29871330
[No Abstract] [Full Text] [Related]
40. A facile lentiviral vector system for expression of doxycycline-inducible shRNAs: knockdown of the pre-miRNA processing enzyme Drosha.
Aagaard L; Amarzguioui M; Sun G; Santos LC; Ehsani A; Prydz H; Rossi JJ
Mol Ther; 2007 May; 15(5):938-45. PubMed ID: 17311008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
